Showing results (1351-1360 of 1,568) with videos related to

Sort By:
Pageof 157
Expert Review of Hematology|February 1, 2018
The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with hemophiliaHortensia De la Corte-Rodriguez, E Carlos Rodriguez-Merchan, M Teresa Alvarez-Roman, et al.
Expert Review of Hematology|December 25, 2018
Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxisLeland Metheny, Marcos de Lima
Expert Review of Hematology|March 16, 2018
Regulatory role of thiol isomerases in thrombus formationAnish Sharda, Bruce Furie
Expert Review of Hematology|June 6, 2022
Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trialsMuhammad Rafay Khan Niazi, Divya Chukkalore, Abdullah Jahangir, et al.
Expert Review of Hematology|June 13, 2022
Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment?Markus Raderer, Barbara Kiesewetter, Marius E Mayerhoefer
Expert Review of Hematology|June 27, 2022
Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and managementGiovanna Vitaliti, Valentina Giacchi, Monica Sciacca, et al.
Expert Review of Hematology|June 17, 2022
Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemiaShan Huang, Bo Lu, Mengyuan Zhu, et al.
Expert Review of Hematology|November 18, 2020
Apoptosis targeted therapies in acute myeloid leukemia: an updateSomedeb Ball, Gautam Borthakur
Expert Review of Hematology|November 18, 2020
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practiceMassimo Breccia, Fabio Efficace, Gioia Colafigli, et al.
Expert Review of Hematology|December 17, 2020
A comprehensive overview of daratumumab and carfilzomib and the recently approved daratumumab, carfilzomib and dexamethasone regimen in relapsed/refractory multiple myelomaShambavi Richard, Sundar Jagannath, Hearn Jay Cho, et al.
Pageof 157